P19-02. High protection of female macaques from repeated intravaginal challenges with SHIV-162P3 upon mucosal vaccination with Gp41 subunits-virosomes

por Bomsel, M, Drillet, A, Roger, M, Amacker, M, Mouz, N, Lopalco, L, Devillers, G, Zurbriggen, R, Fleury, S
Publicado 2009

Liposomal formulation of Gp41 derivate with adjuvant MPLA: vaccine design, immunogenicity in animals and safety in humans

por Katinger, D, Wagner, A, Luque, I, Crespillo, S, Conejero-Lara, F, Roger, M, Martin, C, Mouz, N, Mourao, S, Farsang, A, Notka, F, Malcolm, K, Bosquet, N, Le Grand, R, Moog, C, Cope, A, Shattock, R, Lewis, DJ, El Habib, R
Publicado 2012